Paul Tudor Jones Prime Medicine, Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 61,295 shares of PRME stock, worth $326,702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,295Holding current value
$326,702% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRME
# of Institutions
120Shares Held
62.6MCall Options Held
57.7KPut Options Held
66.3K-
Alphabet Inc. Mountain View, CA15.1MShares$80.3 Million4.68% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.99MShares$31.9 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.8MShares$30.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$20 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.36MShares$17.9 Million0.02% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $510M